MetaRon

MetaRon predicts operons in metagenomic and whole-genome sequence data to identify operonic structures and support studies of gene regulation and microbial community function without requiring functional or experimental annotations.

Key Features:

• Data processing: Processes filtered raw reads and assembles into scaffolds using IDBA as part of a pipeline for metagenomic and whole-genome inputs.
• Gene prediction: Performs gene prediction using Prodigal.
• Operon prediction criteria: Predicts operons based on gene co-directionality, intergenic distance (IGD), and promoter presence without requiring prior functional or experimental annotations.
• Benchmark performance: Achieved 97.8% sensitivity, 94.1% specificity, and 92.4% accuracy on E. coli MG1655 whole-genome data; 93.7% sensitivity, 75.5% specificity, and 88.1% accuracy on a simulated mixture of E. coli MG1655, Mycobacterium tuberculosis H37Rv, and Bacillus subtilis str. 16; and 87% sensitivity, 91% specificity, and 88% accuracy on the draft genome of E. coli c20 from chicken gut data.
• Scalability: Identified 1,232,407 unique operons across 145 paired-end human gut metagenome samples.
• Generalizability and data management: Predicts operons across unrelated bacterial genomes and handles whole-genome and metagenomic datasets for large-scale analyses.
• Secondary metabolite analysis: Uses operonic data to study trends in secondary metabolites in whole-metagenome samples, reducing data volume while enhancing precision.

Scientific Applications:

• Operon discovery in microbial communities: Identification of operons in complex metagenomic and whole-genome datasets to study gene regulation and operonic structure.
• Disease association discovery: Detection of operons associated with type 2 diabetes (T2D), including links to Maltose phosphorylase (K00691), 3-deoxy-D-glycero-D-galacto-nononate 9-phosphate synthase (K21279), and an uncharacterized protein (K07101).
• Secondary metabolite trend analysis: Analysis of operon-derived signals to assess secondary metabolite patterns in metagenomes and their relation to disease states such as T2D.
• Therapeutic metagenomics and host-microbe interactions: Informing studies of host-microbe interactions and therapeutic metagenomics by revealing operonic structures that influence microbial gene expression.

Methodology:

Starts from filtered raw reads, assembles into scaffolds using IDBA, performs data manipulation and gene prediction with Prodigal, and predicts operons based on gene co-directionality, intergenic distance (IGD), and promoter presence.